dalteparin has been researched along with Bewilderment in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Ardes, D | 1 |
| Carrarini, C | 1 |
| Russo, M | 1 |
| Dono, F | 1 |
| Speranza, R | 1 |
| Digiovanni, A | 1 |
| Martinotti, G | 1 |
| Di Iorio, A | 1 |
| Onofrj, M | 1 |
| Cipollone, F | 1 |
| Bonanni, L | 1 |
1 other study available for dalteparin and Bewilderment
| Article | Year |
|---|---|
Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization.
Topics: Aged; Aged, 80 and over; Anticoagulants; C-Reactive Protein; Cognition Disorders; Cohort Studies; Co | 2021 |